Analysis of Methamphetamine and Amphetamine in Oral Fluid of Eleven Drug Abusers

마약남용자 11명의 타액 중 메스암페타민의 분석

  • Kim, Eun-Mi (Narcotics Analysis Division, National Institute of Scientific Investigation) ;
  • Lee, Ju-Seon (Narcotics Analysis Division, National Institute of Scientific Investigation) ;
  • Choi, Hye-Young (Narcotics Analysis Division, National Institute of Scientific Investigation) ;
  • Choi, Hwa-Kyung (Narcotics Analysis Division, National Institute of Scientific Investigation) ;
  • Chung, Hee-Sun (Narcotics Analysis Division, National Institute of Scientific Investigation)
  • 김은미 (국립과학수사연구소 마약분석과) ;
  • 이주선 (국립과학수사연구소 마약분석과) ;
  • 최혜영 (국립과학수사연구소 마약분석과) ;
  • 최화경 (국립과학수사연구소 마약분석과) ;
  • 정희선 (국립과학수사연구소 마약분석과)
  • Published : 2008.12.31

Abstract

A qualitative and quantitative analytical method was developed for detection of methamphetamine (MA) and its main metabolite amphetamine (AM) in oral fluid. Oral fluids of eleven drug abusers were provided by Police, specimens were collected by stimulation with a cotton swab treated with 20 mg of citric acid ($Salivette^{(R)}$; Sarstedt, USA). As the preliminary test, oral fluid samples were screened for amphetamines by Fluorescence Polarization Immunoassay (TDxFLx, Abbott Co.). Extraction for MA was performed using solid-phase extraction (SPE) by $RapidTrace^{TM}$ (Zymark, USA) with mixed mode cation exchange cartridge, CLEAN $SCREEN^{(R)}$ (130 mg/3 ml, UCT) after dilution with phosphate buffer. Samples were evaporated and derivatized by pentafluoropropionic acid anhydride (PFPA). Quantitation of MA and AM was performed by gas chromatography-mass spectrometry (GC-MS) using selective ion monitoring (SIM), the quantitation ions were m/z 204 (MA), 208 (MA-$D_5$), 190 (AM) and 194 (AM-$D_5$). The selectivity, linearity of calibration, limit of detection (LOD) and quantification (LOQ) within- and between day precision, accuracy and recoveries were examined as parts of the method validation. All oral fluid samples gave positive results to immunoassay for MA (cut-off level, 50 ng/ml as d-amphetamine). Concentrations of MA and AM by GC-MS in eleven samples were ranged 104.2${\sim}$4603.3 ng/ml and 32.4${\sim}$268.6 ng/ml, respectively. Extracted calibration curves of MA and AM were linear over the two concentration range of 1${\sim}$100 and 50${\sim}$1000 ng/ml with correlation coefficient of above 0.999. LOQ of MA and AM was 1 and 3 ng/ml, respectively. The intraand inter-day run precisions (CV) for MA and AM were less than 10%, and the accuracies (bias) for MA and AM were also less than 10% at the two different concentrations 5 and 100 ng/ml at low calibration range, 50 and 1000 ng/ml at high calibration range. The absolute recoveries of MA and AM at low and high calibration ranges were more than 82% and 75%, respectively. In this study the qualitative and quantitative analytical method of MA in oral fluid was established. Oral fluid testing may detect drug use in past hours because of its shorter detection window than urine, and be useful in post-accident situations. So oral fluids will be most useful for testing drug abuse in the driving under the influence of drug (DUID) as the alternative specimens of urine.

Keywords

References

  1. 유영찬 : 법과학과 수사, 현암사 (2002)
  2. 정희선 : 생체시료에서 마약류의 검사, 신일상사 (2000)
  3. Maxwell, J. C. : Emerging research on methamphetamine. Curr. Opi. Psychiatry 18, 235 (2005) https://doi.org/10.1097/01.yco.0000165592.52811.84
  4. Baselt, R. C. : Disposition of Toxic Drugs and Chemicals in Man 7th edi. Biomedical Publications (2004)
  5. Beckett, A. H. and Rowland, M. : Urinary excretion kinetics of methylamphetamine and amphetamine in man. J. Pharm. Pharmac. 17(Suppl.), 109 (1965) https://doi.org/10.1111/j.2042-7158.1965.tb07757.x
  6. Oyler, J. M., Cone, E. J., Joseph, Jr. R. E., Moolchan, E. T. and Huestis, M. A. : Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clin. Chem. 48, 1703 (2002)
  7. Bush, D. M. : The U.S. mandatory guidelines for federal workplace drug testing programs: Current status and future considerations. Forensic Sci. Int. 174, 111 (2008) https://doi.org/10.1016/j.forsciint.2007.03.008
  8. Huestis, M. A. and Cone, E. J. : Methamphetamine disposition in oral fluid, plasma, and urine. Ann. N.Y. Acad. Sci. 1098, 104 (2007) https://doi.org/10.1196/annals.1384.038
  9. Levine, B. : Principles of Forensic Toxicology, 2nd edi., AASS Press (2003)
  10. DHHS. Proposed revisions to mandatory guidelines for federal workplace drug testinh programs. Fed. Register 69, 19673 (2004)
  11. Kim, E., Lee, J., Choi, S., Lim, M. and Chung, H. : Analysis of ketamine and norketamine in urine by automatic solid-phase extraction (SPE) and positive ion chemical ionization-gas chromatography-mass spectrometry (PCI-GC-MS). Forensic. Sci. Int. 174, 197 (2008) https://doi.org/10.1016/j.forsciint.2007.04.217
  12. Kim, E., Lee, J., Park, M., Choi, S., Lim, M. and Chung, H. : Standardization of method for the analysis of dextraomethorphan in urine. Forensic. Sci. Int. 161, 198 (2006) https://doi.org/10.1016/j.forsciint.2005.12.034
  13. 김은미, 이주선, 최혜영, 임미애, 정희선 : 고상추출법 및 NCIGC-MS를 이용한 소변 중 15종 벤조디아제핀계 약물 동시분석. 한국법과학회지 8, 24 (2007)
  14. 김은미 : 우리나라 마약류 남용현황 및 생체시료중 마약류 분석 동향, 관세청주관 마약.식품 분석과학기술 세미나 (2008.6.14)
  15. Verstraete, A. G. : Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic. Sci. Int. 150, 143 (2005) https://doi.org/10.1016/j.forsciint.2004.11.023
  16. Verstraete, A. G. and Pierce, A. : Workplace drug testing in europe. Forensic. Sci. Int. 121, 2 (2001) https://doi.org/10.1016/S0379-0738(01)00445-5
  17. 최혜영, 이주선, 최상길, 김은미, 김재균, 김영운, 임미애, 정희선 : 음주운전자 275명 혈액 중 마약류 및 남용약물의 분석. 약학회지 52(2), 137 (2008)
  18. Drummer, O. H. : Drug testing in oral fluid. Clin. Biochem. Rev. 27, 147 (2006)
  19. Schepers, R. J., Oyler, J. M., Joseph, Jr. R. E., et al. : Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin. Chem. 49, 121 (2003) https://doi.org/10.1373/49.1.121